Delivery Order SPE2DB22D3301-SPE2DB24FY6BT
Award Date
5/3/24
Potential Completion Date
5/6/24
Potential Value
$1.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lidocaine HCL 1% vials, valued at $1,351.13, with a completion date of March 20, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00,...
This federal contract award, with an ID of SPE2DX15D2223|SPE2DX25F4DHA, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp. The contract is for the delivery of 4,566,286,197 units of Lidocaine HCL 2% Luer-Jet 5ML, a pharmaceutical product. The contract has a ceiling value of $2,809.98 and a firm fixed-price pricing type. It is a delivery order with a completion date of November 1, 2024. Amerisourcebergen Drug Corp is a...
This federal contract award, with the ID SPE2DB22D3301|SPE2DB25FX4XC, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $2,676.96 firm fixed-price delivery order is for the supply of 4566325055 - Lidocaine HCL 2% 100 mg/5 ml, 5 ml. The contract has an ultimate completion date of November 5, 2024 and was awarded on November 4, 2024. This appears to be a delivery order against a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen...
This federal contract award, valued at $2,518.26, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567455299 - Lidocaine HCL 1% Vial 50ML, with a completion date of March 5, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type, and does not have a set-aside designation. Amerisourcebergen is the prime contractor for this award, and it...
This federal contract award to Amerisourcebergen Drug Corp is a delivery order (SPE2DB23FP5Q4) valued at $1,628.10 for the supply of Lidocaine HCL 2% in 5 mL vials. The award was made by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract has an ultimate completion date of August 30, 2023 and is a firm fixed price agreement. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with...
This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Lidocaine HCL 2% 200 mg/10 ml, 10 ml vials. The contract, valued at $6,808.26, is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) on February 28, 2024, with a completion date of February 29, 2024. The award is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,327,622 units of Lidocaine HCl 2% Luer-Jet 5mL. The award has a ceiling value of $1,104.89 and is a firm fixed price contract. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00, which serves as the primary vehicle for the company to provide a...
The U.S. Defense Logistics Agency (DLA) awarded Delivery Order SPE2DB24FXXW9 to Amerisourcebergen Drug Corp, Corporate Office Division, with a ceiling value of $1,378.15. This firm-fixed price contract is for the supply of 4,564,558,341 units of Lidocaine HCL 4% Solution 4ML. The contract has an ultimate completion date of May 10, 2024. This delivery order is issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Lidocaine HCL 1% vials, a critical medical commodity. The contract has a ceiling value of $4,880.63 and a period of performance through January 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $6,214.99, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,561,611,525 units of Lidocaine HCL 2% Luer-Jet 5ML, a medical product used in various healthcare applications. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA...